FORM 8-K

Company

Corvus Pharmaceuticals, Inc.

Filed

December 16, 2019

Period of Report

December 12, 2019

Accession Number

0001171843-19-008140

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →